CD4 and non-small cell lung carcinoma: The present study showed that the proportion of CD45RA-CD4 + T cells was associated with PFS after the start of ICI therapy, independent of several clinical background factors, indicating that peripheral CD4 memory T cells are associated with the efficacy of ICIs for treating NSCLC patients.